| P2093 | author name string | Angela M Floden | |
| | Robert A Gaultney | |
| | Tammy Gonzalez | |
| | Catherine A Brissette | |
| P2860 | cites work | Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi | Q22122357 |
| | Lyme Disease | Q22250902 |
| | The Lyme vaccine: a cautionary tale | Q22251377 |
| | Hidden in plain sight: Borrelia burgdorferi and the extracellular matrix | Q22251447 |
| | Human pathogenic Borrelia spielmanii sp. nov. resists complement-mediated killing by direct binding of immune regulators factor H and factor H-like protein 1 | Q24672482 |
| | Crystal structure of Lyme disease variable surface antigen VlsE of Borrelia burgdorferi | Q27638660 |
| | A bacterial genome in flux: the twelve linear and nine circular extrachromosomal DNAs in an infectious isolate of the Lyme disease spirochete Borrelia burgdorferi | Q28144621 |
| | Lyme borreliosis | Q29013670 |
| | A monoclonal antibody generated by antigen inoculation via tick bite is reactive to the Borrelia burgdorferi Rev protein, a member of the 2.9 gene family locus | Q32105929 |
| | Long-term study of cell-mediated responses to Borrelia burgdorferi in the laboratory mouse | Q33595436 |
| | The borrelial fibronectin-binding protein RevA is an early antigen of human Lyme disease | Q33627104 |
| | Serum complement sensitivity as a key factor in Lyme disease ecology. | Q33751851 |
| | Kinetics and in vivo induction of genetic variation of vlsE in Borrelia burgdorferi | Q33757680 |
| | Genetic variation of the Borrelia burgdorferi gene vlsE involves cassette-specific, segmental gene conversion | Q33757693 |
| | Borrelia burgdorferi RevA antigen is a surface-exposed outer membrane protein whose expression is regulated in response to environmental temperature and pH | Q34008806 |
| | Delays and diversions mark the development of B cell responses to Borrelia burgdorferi infection | Q34031718 |
| | Approaches toward the directed design of a vaccine against Borrelia burgdorferi | Q34543900 |
| | Borrelia burgdorferi lacking BBK32, a fibronectin-binding protein, retains full pathogenicity | Q34681119 |
| | Serologic proteome analysis of Borrelia burgdorferi membrane-associated proteins | Q34721407 |
| | Borrelia burgdorferi and its tropisms for adhesion molecules in the joint. | Q34739476 |
| | Laboratory maintenance of Borrelia burgdorferi | Q34821083 |
| | Temporal analysis of Borrelia burgdorferi Erp protein expression throughout the mammal-tick infectious cycle | Q34945715 |
| | Adhesion mechanisms of the Lyme disease spirochete, Borrelia burgdorferi | Q35010698 |
| | Global analysis of Borrelia burgdorferi genes regulated by mammalian host-specific signals | Q35011172 |
| | 'Nothing is permanent but change'- antigenic variation in persistent bacterial pathogens | Q35968220 |
| | Lyme borreliosis spirochete Erp proteins, their known host ligands, and potential roles in mammalian infection | Q36999798 |
| | Borrelia burgdorferi RevA antigen binds host fibronectin | Q37256541 |
| | Fibronectin: a multidomain host adhesin targeted by bacterial fibronectin-binding proteins | Q37778852 |
| | Early and late cutaneous manifestations in Ixodes-borne borreliosis (erythema migrans borreliosis, Lyme borreliosis). | Q39540066 |
| | Complement-mediated serum sensitivity among spirochetes that cause Lyme disease. | Q39829393 |
| | A reverse transcriptase-polymerase chain reaction assay of Borrelia burgdorferi 16S rRNA for highly sensitive quantification of pathogen load in a vector | Q43220298 |
| | Dermatologic manifestations of Lyme disease | Q44634069 |
| | Fibronectin-binding activity in Borrelia burgdorferi1. | Q47760192 |
| | Analysis of Borrelia burgdorferi gene expression during life cycle phases of the tick vector Ixodes scapularis. | Q52591505 |
| | Multiplex PCR as a tool for validating plasmid content of Borrelia burgdorferi. | Q54369916 |
| | The Spirochetal Etiology of Lyme Disease | Q58402764 |
| | Inactivation of the fibronectin-binding adhesin genebbk32significantly attenuates the infectivity potential ofBorrelia burgdorferi | Q62966001 |
| | Characterization of Borrelia burgdorferi associated antigens by monoclonal antibodies | Q67245001 |
| | Experimental Lyme arthritis in rats infected with Borrelia burgdorferi | Q68091421 |
| | Etiology of the acrodermatitis chronica atrophicans lesion in Lyme disease | Q71237076 |
| | Persistence of Borrelia burgdorferi in ligamentous tissue from a patient with chronic Lyme borreliosis | Q72607871 |
| | Heterogeneity in the complement-dependent bacteriolysis within the species of Borrelia burgdorferi | Q73313091 |
| | Insights from a novel three-dimensional in vitro model of lyme arthritis: standardized analysis of cellular and molecular interactions between Borrelia burgdorferi and synovial explants and fibroblasts | Q73521683 |
| | Borrelia burgdorferi-specific monoclonal antibodies derived from mice primed with Lyme disease spirochete-infected Ixodes scapularis ticks | Q74582507 |
| | The role of VlsE antigenic variation in the Lyme disease spirochete: persistence through a mechanism that differs from other pathogens | Q80832075 |
| | Cultivation of Borrelia burgdorferi in dialysis membrane chambers in rat peritonea | Q81928321 |
| | Summary of notifiable diseases: United States, 2009 | Q84088142 |
| | Lyme borreliosis | Q94329194 |
| P433 | issue | 6 | |
| P921 | main subject | Lyme disease | Q201989 |
| | Borrelia burgdorferi | Q2723634 |
| P304 | page(s) | 892-899 | |
| P577 | publication date | 2013-04-17 | |
| P1433 | published in | Clinical and Vaccine Immunology | Q5133811 |
| P1476 | title | Evaluation of RevA, a fibronectin-binding protein of Borrelia burgdorferi, as a potential vaccine candidate for lyme disease | |
| P478 | volume | 20 | |